Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06492187 · ClinicalTrials.gov registry record
Triage Survey for Infectious Disease Eligibility
A clinical trial of HIV-1-infection and Infectious Disease, sponsored by Brooklyn Clinical Research.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT06492187: Recruiting study of HIV-1-infection and Infectious Disease, sponsored by Brooklyn Clinical Research.
NCT06492187 is a study of HIV-1-infection and Infectious Disease that is actively recruiting participants, run by Brooklyn Clinical Research. The registered enrollment target is 10,000 participants, above the 211-participant average among 71 other HIV-1-infection trials with a reported enrollment target (4639% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06492187, a study of HIV-1-infection and Infectious Disease, is actively recruiting participants, sponsored by Brooklyn Clinical Research.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
SWIFT-ID-101 is a single site survey study designed to assess potential participants' eligibility to screen for industry-sponsored clinical trials for diagnosis, treatment, or prevention of infectious diseases such as in the areas of HIV, vaccines, and other infectious-diseases areas. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical/surgical history, physical examination, comorbidities, and any current symptoms. Informed consent will be done electronically (preferable) or on paper. Informed consent may be done in-person or remotely, depending on patient preference. Information related to HIV, hepatitis B and C, other infectious diseases, or substance use disorder will also be obtained if applicable. Site staff may collect vital signs, fingerpick testing, urine drug screens, blood draws, EKG, and pregnancy tests. Some testing may be recommended in a fasting condition. A doctor will review medical history and results of the above evaluations with the participant to determine study suitability via clinical interview. The doctor may reach out to the patient's current treating physicians, other providers, and pharmacies to determine eligibility for clinical trials. A follow-up phone call may be needed to discuss testing results and/or trial eligibility. If a participant is deemed eligible for future trials and if the participant remains interested, counseling on contraception requirements for trials will be discussed.
Primary Outcome
Number of participants for whom an industry-sponsored clinical research clinical research is clinically appropriate for HIV, vaccines, and other infectious diseases
Conditions Studied
Study Locations (1)
New York
- Brooklyn Clinical Research - Brooklyn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2024-06-28 |
| Est. Completion | 2029-01-28 |
What NCT06492187 shows while recruiting
NCT06492187 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 211-participant average among 71 other HIV-1-infection trials with a reported enrollment target (4639% higher).
The record links to 3 conditions, with HIV-1-infection appearing as the primary indexed condition, and to 0 interventions.
NCT06492187 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06492187 about?
NCT06492187 is a clinical study titled "Triage Survey for Infectious Disease Eligibility". SWIFT-ID-101 is a single site survey study designed to assess potential participants' eligibility to screen for industry-sponsored clinical trials for diagnosis, treatment, or prevention of infectious diseases such as in the areas of HIV, vaccines, and other infectious-diseases areas. A physician wi...
What is the current status of trial NCT06492187?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2024-06-28. Estimated completion is 2029-01-28.
What conditions does trial NCT06492187 study?
This clinical trial studies the following conditions: HIV-1-infection, Infectious Disease, Vaccination; Infection.
Who is sponsoring clinical trial NCT06492187?
This trial is sponsored by Brooklyn Clinical Research, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06492187 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV-1-infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06492187's enrollment target sits among peer trials
10,000 1st of 71 higher than 71 of 71 other HIV-1-infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV-1-infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Coronary Vascular Health in Women
RECRUITING · Phase 2
-
Study of GS-3242 in Participants With HIV-1; Substudy-05
RECRUITING · Phase 1
-
Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers
RECRUITING · NA
-
Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States
RECRUITING
-
Ending the Epidemic Interventions in the Dental Setting - UH3
RECRUITING · NA
-
Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI